Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
作者信息
Mahadi Ashrafur Rahaman
机构信息
Central Medical College, Cumilla, Bangladesh.
出版信息
Front Public Health. 2021 Dec 17;9:770593. doi: 10.3389/fpubh.2021.770593. eCollection 2021.
Abstract
摘要
相似文献
1
Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
Front Public Health. 2021 Dec 17;9:770593. doi: 10.3389/fpubh.2021.770593. eCollection 2021.
2
Antimicrobial resistance in low- and middle-income countries: current status and future directions.
Expert Rev Anti Infect Ther. 2022 Feb;20(2):147-160. doi: 10.1080/14787210.2021.1951705. Epub 2021 Jul 19.
3
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
Int J Infect Dis. 2021 Mar;104:250-254. doi: 10.1016/j.ijid.2020.12.087. Epub 2021 Jan 9.
4
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
J Antimicrob Chemother. 2021 Oct 11;76(11):3045-3058. doi: 10.1093/jac/dkab300.
5
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
6
Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
Clin Infect Dis. 2021 May 4;72(9):1657-1659. doi: 10.1093/cid/ciaa773.
7
Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments.
Curr Opin Microbiol. 2021 Dec;64:91-99. doi: 10.1016/j.mib.2021.09.013. Epub 2021 Oct 13.
8
Raising awareness of antimicrobial resistance in rural aquaculture practice in Bangladesh through digital communications: a pilot study.
Glob Health Action. 2019;12(sup1):1734735. doi: 10.1080/16549716.2020.1734735.
9
A disparity in the number of studies related to COVID-19 and SARS-CoV-2 between low- and middle-income countries and high-income countries.
Int Health. 2021 Jul 3;13(4):379-381. doi: 10.1093/inthealth/ihaa088.
10
Treatment of COVID-19: implications for antimicrobial resistance in Africa.
Pan Afr Med J. 2020 Jul 20;35(Suppl 2):119. doi: 10.11604/pamj.supp.2020.35.23713. eCollection 2020.
引用本文的文献
1
Antibiotic usage patterns in COVID-19 patients in five tertiary hospitals from Bangladesh: A countrywide picture.
IJID Reg. 2024 May 31;12:100381. doi: 10.1016/j.ijregi.2024.100381. eCollection 2024 Sep.
2
The Role of Uncertainty and Negative Emotion in Chinese Parents' Self-Medication of Children with Antibiotics.
Int J Environ Res Public Health. 2023 Aug 18;20(16):6603. doi: 10.3390/ijerph20166603.
3
Prevalence and Antibiotic Resistance Pattern of , , and in Two Reference Hospitals of Yaoundé: An Overview before and during COVID-19 Pandemic Era.
Antibiotics (Basel). 2023 May 18;12(5):929. doi: 10.3390/antibiotics12050929.
4
Indiscriminate Use of Antibiotics for COVID-19 Treatment in South Asian Countries is a Threat for Future Pandemics Due to Antibiotic Resistance.
Clin Pathol. 2022 May 18;15:2632010X221099889. doi: 10.1177/2632010X221099889. eCollection 2022 Jan-Dec.
本文引用的文献
1
Antibiotic Prescribing Patterns at COVID-19 Dedicated Wards in Bangladesh: Findings from a Single Center Study.
Infect Prev Pract. 2021 Jun;3(2):100134. doi: 10.1016/j.infpip.2021.100134. Epub 2021 Feb 27.
2
Use of Antimicrobials among Suspected COVID-19 Patients at Selected Hospitals, Bangladesh: Findings from the First Wave of COVID-19 Pandemic.
Antibiotics (Basel). 2021 Jun 18;10(6):738. doi: 10.3390/antibiotics10060738.
3
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?
J Infect Public Health. 2021 May;14(5):555-560. doi: 10.1016/j.jiph.2021.02.011. Epub 2021 Mar 5.
4
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
5
Lessons learned from COVID-19 for the post-antibiotic future.
Global Health. 2020 Oct 8;16(1):94. doi: 10.1186/s12992-020-00623-x.
6
Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements.
BMJ Glob Health. 2020 Aug;5(8). doi: 10.1136/bmjgh-2020-003042.
7
COVID-19 and Bangladesh: Challenges and How to Address Them.
Front Public Health. 2020 Apr 30;8:154. doi: 10.3389/fpubh.2020.00154. eCollection 2020.
8
Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status.
Int J Antimicrob Agents. 2020 Apr;55(4):105946. doi: 10.1016/j.ijantimicag.2020.105946. Epub 2020 Mar 19.
9
What Will It Take to Address the Global Threat of Antibiotic Resistance?
J Law Med Ethics. 2015 Summer;43(2):363-8. doi: 10.1111/jlme.12253.
10
Self medicated antibiotics in Bangladesh: a cross-sectional health survey conducted in the Rajshahi City.
BMC Public Health. 2014 Aug 14;14:847. doi: 10.1186/1471-2458-14-847.
Zotero 插件